TY - JOUR T1 - Circulating interleukin-6 levels and incident ischemic stroke: a systematic review and meta-analysis of population-based cohort studies JF - medRxiv DO - 10.1101/2021.03.27.21254451 SP - 2021.03.27.21254451 AU - Andreas Papadopoulos AU - Konstantinos Palaiopanos AU - Harry Björkbacka AU - Annette Peters AU - James A. de Lemos AU - Sudha Seshadri AU - Martin Dichgans AU - Marios K. Georgakis Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/29/2021.03.27.21254451.abstract N2 - Objective To determine the association between circulating interleukin-6 (IL-6) levels and risk of incident ischemic stroke in the general population.Methods Following the PRISMA guidelines, we systematically searched the literature for population-based prospective cohort studies exploring the association between circulating IL-6 levels and risk of incident ischemic stroke. We pooled association estimates for ischemic stroke risk with random-effect meta-analyses and explored non-linear effects in dose-response meta-analyses. Risk of bias was assessed with the Newcastle-Ottawa scale (NOS).Results We identified 11 studies (n=27,411 individuals; 2,669 incident stroke cases) meeting our eligibility criteria. Overall, quality of the included studies was high (median 8 out of 9 NOS points). In meta-analyses, 1-standard deviation increment in circulating IL-6 levels was associated with a 19% increase in risk of incident ischemic stroke over a mean follow-up of 12.4 years (RR 1.19; 95% CI 1.10 to 1.28). A dose-response meta-analysis showed a linear association between circulating IL-6 levels and ischemic stroke risk. There was only moderate heterogeneity and the results were consistent in sensitivity analyses restricted to studies of low risk of bias and studies fully adjusting for demographic and vascular risk factors. The results also remained stable following adjustment for publication bias.Conclusions Higher circulating IL-6 levels in community-dwelling individuals are associated with higher long-term risk of incident ischemic stroke in a linear pattern and independently of conventional vascular risk factors. Along with findings from genetic studies and clinical trials, these results provide additional support for a key role of IL-6 signaling in ischemic stroke.Competing Interest StatementThe authors have declared no competing interest.Funding StatementHB is supported by the Swedish Research Council and the Swedish Heart-Lung Foundation. The analysis from the Framingham Heart Study has been funded from NHLBI: HHSN 268201500001I and NINDS grant R01 NS017950 (SS). MD is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy - ID 390857198) and as part of CRC 1123 (B3) and DI 722/16-1. MKG has received funding from the Onassis Foundation, the German Academic Exchange Service, and the Vascular Dementia Research Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Participants from all included studies provided informed consent and all included studies have obtained ethical approval from the relevant Institutional Review Board(s). This manuscript does not contain individual-level data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData not provided in the article due to space limitations will be made available upon reasonable request to the corresponding author. ER -